These findings are consistent with prior reported improved lung inflammation, vasculitis, and associated improved survival in Serp‐1‐treated MHV68 gamma herpesvirus‐infected mouse model (Lomas et al, 1993; Nash et al, 1997; Chen et al, 2013; Yaron et al, 2020). This evidence concerns the gene SERP1 and vasculitis.